ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 96 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2014. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $19,377,000 | +11.6% | 3,621,895 | +17.5% | 0.00% | 0.0% |
Q3 2016 | $17,359,000 | +9.5% | 3,083,249 | +6.8% | 0.00% | +33.3% |
Q2 2016 | $15,847,000 | -23.1% | 2,886,566 | +4.0% | 0.00% | -40.0% |
Q1 2016 | $20,601,000 | -14.0% | 2,776,467 | -3.7% | 0.01% | -16.7% |
Q4 2015 | $23,963,000 | -2.3% | 2,883,598 | +5.9% | 0.01% | 0.0% |
Q3 2015 | $24,533,000 | -25.4% | 2,722,883 | -0.6% | 0.01% | -25.0% |
Q2 2015 | $32,883,000 | +19.6% | 2,740,240 | +7.3% | 0.01% | +14.3% |
Q1 2015 | $27,492,000 | +138.5% | 2,552,648 | +12.3% | 0.01% | +133.3% |
Q4 2014 | $11,529,000 | +122.0% | 2,273,949 | +15.6% | 0.00% | +200.0% |
Q3 2014 | $5,194,000 | -36.6% | 1,967,326 | -3.2% | 0.00% | -50.0% |
Q2 2014 | $8,190,000 | -20.6% | 2,032,142 | -9.8% | 0.00% | -33.3% |
Q1 2014 | $10,313,000 | +9.9% | 2,251,715 | +4.2% | 0.00% | 0.0% |
Q4 2013 | $9,381,000 | +26.0% | 2,161,628 | +14.4% | 0.00% | 0.0% |
Q3 2013 | $7,446,000 | +111.2% | 1,889,858 | +13.1% | 0.00% | +200.0% |
Q2 2013 | $3,526,000 | – | 1,671,309 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MSD Partners, L.P. | 15,151,516 | $38,182,000 | 7.99% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 10,406,850 | $26,225,000 | 4.02% |
MILLER VALUE PARTNERS, LLC | 12,385,586 | $31,211,000 | 1.12% |
CHIRON CAPITAL MANAGEMENT, LLC | 201,470 | $508,000 | 0.41% |
Sargent Investment Group, LLC | 289,025 | $728,000 | 0.26% |
MAGNOLIA CAPITAL ADVISORS LLC | 80,542 | $404,000 | 0.16% |
XTX MARKETS LLC | 11,086 | $28,000 | 0.14% |
Virtus ETF Advisers LLC | 99,108 | $250,000 | 0.13% |
Old West Investment Management, LLC | 210,226 | $529,000 | 0.12% |
EQUITEC PROPRIETARY MARKETS, LLC | 31,300 | $79,000 | 0.06% |